| Protein NMR spectroscopy: principles and practice J Cavanagh Academic press, 1996 | 4448 | 1996 |
| ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets AJ Souers, JD Leverson, ER Boghaert, SL Ackler, ND Catron, J Chen, ... Nature medicine 19 (2), 202-208, 2013 | 3082 | 2013 |
| IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis E Varfolomeev, JW Blankenship, SM Wayson, AV Fedorova, N Kayagaki, ... Cell 131 (4), 669-681, 2007 | 1430 | 2007 |
| Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 IE Wertz, S Kusam, C Lam, T Okamoto, W Sandoval, DJ Anderson, ... Nature 471 (7336), 110-114, 2011 | 868 | 2011 |
| From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors A Ashkenazi, WJ Fairbrother, JD Leverson, AJ Souers Nature reviews drug discovery 16 (4), 273-284, 2017 | 851 | 2017 |
| c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation E Varfolomeev, T Goncharov, AV Fedorova, JN Dynek, K Zobel, ... Journal of Biological Chemistry 283 (36), 24295-24299, 2008 | 668 | 2008 |
| Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy JD Leverson, DC Phillips, MJ Mitten, ER Boghaert, D Diaz, SK Tahir, ... Science translational medicine 7 (279), 279ra40-279ra40, 2015 | 546 | 2015 |
| Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax) JD Leverson, H Zhang, J Chen, SK Tahir, DC Phillips, J Xue, P Nimmer, ... Cell death & disease 6 (1), e1590-e1590, 2015 | 488 | 2015 |
| Structure-guided design of a selective BCL-XL inhibitor G Lessene, PE Czabotar, BE Sleebs, K Zobel, KN Lowes, JM Adams, ... Nature chemical biology 9 (6), 390-397, 2013 | 427 | 2013 |
| c‐IAP1 and UbcH5 promote K11‐linked polyubiquitination of RIP1 in TNF signalling JN Dynek, T Goncharov, EC Dueber, AV Fedorova, A Izrael‐Tomasevic, ... The EMBO journal 29 (24), 4198-4209, 2010 | 399 | 2010 |
| Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3 X Sun, J Yin, MA Starovasnik, WJ Fairbrother, VM Dixit Journal of Biological Chemistry 277 (11), 9505-9511, 2002 | 389 | 2002 |
| SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) D Vucic, K Deshayes, H Ackerly, MT Pisabarro, S Kadkhodayan, ... Journal of biological chemistry 277 (14), 12275-12279, 2002 | 332 | 2002 |
| ICEBERG: a novel inhibitor of interleukin-1β generation EW Humke, SK Shriver, MA Starovasnik, WJ Fairbrother, VM Dixit Cell 103 (1), 99-111, 2000 | 325 | 2000 |
| Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity ZF Tao, L Hasvold, L Wang, X Wang, AM Petros, CH Park, ER Boghaert, ... ACS medicinal chemistry letters 5 (10), 1088-1093, 2014 | 308 | 2014 |
| Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models EA Punnoose, JD Leverson, F Peale, ER Boghaert, LD Belmont, N Tan, ... Molecular cancer therapeutics 15 (5), 1132-1144, 2016 | 297 | 2016 |
| Solution structure of the fourth metal-binding domain from the Menkes copper-transporting ATPase J Gitschier, B Moffat, D Reilly, WI Wood, WJ Fairbrother Nature structural biology 5 (1), 47-54, 1998 | 289 | 1998 |
| Structure of C3b in complex with CRIg gives insights into regulation of complement activation C Wiesmann, KJ Katschke, JP Yin, KY Helmy, M Steffek, WJ Fairbrother, ... Nature 444 (7116), 217-220, 2006 | 287 | 2006 |
| Exploring protein–protein interactions with phage display SS Sidhu, WJ Fairbrother, K Deshayes Chembiochem 4 (1), 14-25, 2003 | 286 | 2003 |
| The inhibitor of apoptosis proteins as therapeutic targets in cancer D Vucic, WJ Fairbrother Clinical cancer research 13 (20), 5995-6000, 2007 | 282 | 2007 |
| Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152) JA Flygare, M Beresini, N Budha, H Chan, IT Chan, S Cheeti, F Cohen, ... Journal of medicinal chemistry 55 (9), 4101-4113, 2012 | 270 | 2012 |
